PEDIATRICS Vol. 99 No. 2 February 1997, pp. 259 (doi:10.1542/peds.99.2.259)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Calhoun, D. A.
Right arrow Articles by Christensen, R. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Calhoun, D. A.
Right arrow Articles by Christensen, R. D.
Related Collections
Right arrow Blood

PEDIATRICS Vol. 99 No. 2 February 1997, pp. 259-260

EXPERIENCE AND REASON:
The Occurrence of Kostmann Syndrome in Preterm Neonates

The first 300 words of the full text of this article appear below.

    INTRODUCTION

In 1956 Kostmann1 described a condition of repeated bacterial infections in infancy that he termed "infantile genetic agranulocytosis." Patients with this condition have chronic neutropenia, and generally have moderate monocytosis and eosinophilia. Their bone marrow examination is characterized by normal concentrations of granulocyte progenitors and precursors, but an arrested neutrophil development at the promyelocyte or myelocyte stage. These patients typically died in early infancy as a result of overwhelming bacterial infections. Nineteen years after his original description, Kostmann reviewed the published cases of this syndrome, adding ten new cases.2 Over the subsequent years, 120 patients with Kostmann syndrome have been reported.3 No cases, however, have been reported in a neonate delivered before 33 weeks' gestation, and no cases have been reported in patients cared for in a neonatal intensive care unit (NICU). Because the incidence of preterm delivery is about 7%, and 9% to 10% of all deliveries are admitted to a NICU,4 it would have been anticipated that 8 to 12 of the 120 reported patients would have been delivered prematurely or received NICU care.

We recently cared for a neutropenic preterm neonate who died with bacterial sepsis. The neutropenia was ascribed to bacterial infection and no other etiologic explanations were sought. The patient, however, had a twin who also had neutropenia, and in whom the bone marrow aspirate and clinical course were consistent with Kostmann syndrome. On the basis of these twins, we speculate that in preterm infants who die with bacterial sepsis, the diagnosis of Kostmann syndrome can be missed, because their neutropenia can be ascribed solely to bacterial sepsis.5 We speculate further that the reason no preterm infants with Kostmann syndrome have been reported is that they have a high likelihood of dying in the NICU from bacterial sepsis, and that when this occurs the underlying cause of their neutropenia is never . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
NeoReviewsHome page
A. Maheshwari and R. D. Christensen
Neutropenia in the Neonatal Intensive Care Unit
NeoReviews, October 1, 2004; 5(10): e431 - e443.
[Full Text] [PDF]


Home page
PediatricsHome page
D. A. Calhoun, L. M. Rimsza, D. J. Burchfield, M. Millsaps, R. D. Christensen, J. Budania, and J. McCullough
Congenital Autoimmune Neutropenia in Two Premature Neonates
Pediatrics, July 1, 2001; 108(1): 181 - 184.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
J. K. Felix and D. A. Calhoun
Neonatal Alloimmune Neutropenia in Premature Monozygous Twins
Pediatrics, August 1, 2000; 106(2): 340 - 342.
[Abstract] [Full Text]


Home page
PediatricsHome page
D. A. Calhoun, M. Lunøe, Y. Du, A. D. Hutson, M. Veerman, and R. D. Christensen
Granulocyte Colony-Stimulating Factor Serum and Urine Concentrations in Neutropenic Neonates Before and After Intravenous Administration of Recombinant Granulocyte Colony-Stimulating Factor
Pediatrics, February 1, 2000; 105(2): 392 - 397.
[Abstract] [Full Text]